BEONE MEDICINES LTD. (ONC)
BeOne Medicines kondigt financiële resultaten en bedrijfsupdates voor het eerste kwartaal van 2026 aan
BeOne Medicines kondigt financiële resultaten en bedrijfsupdates voor het eerste kwartaal van 2026 aan
BeOne Medicines annuncia i risultati finanziari relativi al primo trimestre 2026 e gli aggiornamenti aziendali
Net Asset Value(s)
Register of shareholders, changes and share capital status – conversion into shares of BONDS series 2 and full early redemption of series A
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in monday.com Ltd. of Class Action Lawsuit and Upcoming Deadlines - MNDY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Snap, Inc. - SNAP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SES AI Corporation of Class Action Lawsuit and Upcoming Deadlines - SES
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Roblox Corporation - RBLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC